Catalyst has secured funding from the Industry Innovation Partnership Program (I2P2) run by the Centre for Aging + Brain Health Innovation (CABHI)

Two studies — in Alberta and Ontario respectively — involve researchers from Alberta Health Services, the University of Alberta, and the University of Waterloo looking at the potential benefits of spencer to support medication adherence for individuals living at home with chronic conditions.

This third party validation helps to shape future sustainability, while developing a deep understanding of patient and system-level benefits.

Click here to read the press release as published on PRWeb.